Lifetime Economic Burden of Crohn’s Disease and Ulcerative Colitis by Age at Diagnosis.

Lifetime Economic Burden of Crohn’s Disease and Ulcerative Colitis by Age at Diagnosis. Clin Gastroenterol Hepatol. 2019 Jul 18;: Authors: Lichtenstein GR, Shahabi A, Seabury SA, Lakdawalla DN, Espinosa OD, Green S, Brauer M, Baldassano RN Abstract BACKGROUND & AIMS: Understanding the burden of Crohn’s disease (CD) and ulcerative colitis (UC) is important for measuring treatment value. We estimated lifetime healthcare costs incurred by patients with CD or UC by age at diagnosis. METHODS: We collected data from 78,620 patients with CD, 85,755 with UC, and propensity score-matched controls from…

Read More

Hormone Therapy for Cancer is a Risk Factor for Relapse of Inflammatory Bowel Diseases.

Hormone Therapy for Cancer is a Risk Factor for Relapse of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2019 Jul 11;: Authors: Axelrad JE, Bazarbashi A, Zhou J, Castañeda D, Gujral A, Sperling D, Glass J, Agrawal M, Hong S, Lawlor G, Hudesman D, Chang S, Shah S, Yajnik V, Ananthakrishnan A, Khalili H, Colombel JF, Itzkowitz S, New York Crohn’s and Colitis Organization (NYCCO) Abstract BACKGROUND & AIMS: Exposure to hormone contraception has been associated with an increased risk of relapse of inflammatory bowel diseases (IBD). Little is known about…

Read More

Ulcerative Colitis and Crohn’s Disease Have the Same Burden and Goals for Treatment.

Ulcerative Colitis and Crohn’s Disease Have the Same Burden and Goals for Treatment. Clin Gastroenterol Hepatol. 2019 Jul 10;: Authors: Le Berre C, Ananthakrishnan AN, Danese S, Singh S, Peyrin-Biroulet L Abstract It is unclear whether ulcerative colitis (UC) is a progressive disease like Crohn’s disease (CD). Patients with UC are often undertreated, because of the possibility of curative colectomy and the perception that the disease burden is lower than that of CD. We discuss findings from studies that aimed to determine whether UC and CD have the same disease…

Read More

Additional Intestinal Mucosal Biopsy Sampling for Research is Safe During Pediatric Endoscopic Procedures.

Related Articles Additional Intestinal Mucosal Biopsy Sampling for Research is Safe During Pediatric Endoscopic Procedures. Clin Gastroenterol Hepatol. 2019 Jul 04;: Authors: Moran CJ, Noreck J, Winter HS, Li EX, Biller JA, Israel EJ, Kaplan JL PMID: 31279952 [PubMed – as supplied by publisher] PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/31279952?dopt=Abstract

Read More

Response to: Value of VAV3 methylation in stool DNA might be restricted to non-thiopurine treated inflammatory bowel disease patients (CGH-D-19-01071).

Related Articles Response to: Value of VAV3 methylation in stool DNA might be restricted to non-thiopurine treated inflammatory bowel disease patients (CGH-D-19-01071). Clin Gastroenterol Hepatol. 2019 Jul 04;: Authors: Kisiel JB, Mahoney DW, Taylor WR, Klepp P PMID: 31279948 [PubMed – as supplied by publisher] PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/31279948?dopt=Abstract

Read More

Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean-a Systematic Review.

Related Articles Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean-a Systematic Review. Clin Gastroenterol Hepatol. 2019 Jun 25;: Authors: Kotze PG, Underwood FE, Damião AOMC, Ferraz JGP, Saad-Hossne R, Toro M, Iade B, Bosques-Padilla F, Teixeira FV, Juliao-Banos F, Simian D, Ghosh S, Panaccione R, Ng SC, Kaplan GG Abstract BACKGROUND & AIMS: The incidence of inflammatory bowel diseases (IBD) is increasing in Latin America. We performed a systematic review to identify clinical and epidemiologic features of IBD in Latin America (including Mexico, Central America, and South…

Read More
<< Go Back